Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers, and health professionals.
Andrea Matus GonzalezNicole EvangelidisMartin HowellAllison JaureBenedicte SautenetMagdalena MaderoGloria AshuntantangSamaya AnumuduAmelie Bernier-JeanLouese DunnYeoungjee ChoLaura Cortes SanabriaIan H de BoerSamuel FungDaniel GallegoChandana GuhaAndrew S LeveyAdeera LevinEduardo LorcaIkechi G OkpechiPatrick RossignolNicole Jane Scholes-RobertsonLaura SolaArmando Teixeira-PintoTim UsherwoodAndrea K ViecelliDavid C WheelerKatherine WiddersMartin WilkieJonathan C Craignull nullPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Across trials in CKD, the outcomes of highest priority to patients, caregivers, and health professionals were kidney function, need for dialysis/transplant, life participation, cardiovascular disease, and death.
Keyphrases
- end stage renal disease
- chronic kidney disease
- peritoneal dialysis
- cardiovascular disease
- clinical trial
- ejection fraction
- newly diagnosed
- prognostic factors
- palliative care
- type diabetes
- randomized controlled trial
- metabolic syndrome
- cross sectional
- patient reported outcomes
- adipose tissue
- skeletal muscle
- phase iii